Trial Profile
Impact of Empiric Nesiritide or Milrinone Infusion on Early Postoperative Recovery Following Fontan Surgery: a Randomized, Double-blind, Placebo-controlled Clinical Trial.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary) ; Milrinone
- Indications Congenital heart defects; Postoperative complications
- Focus Therapeutic Use
- 18 Nov 2013 Primary endpoint 'Event-free-survival-rate' has not been met.
- 18 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 01 Jul 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.